Home / TAK : NYSE

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does TAK make money? Does TAK have pricing power? What's the Earnings Whisper? Will TAK profit more as the business scales? What is TAK's management track record? Is TAK's current price justified?

Takeda Pharmaceutical Company Limited

$20.91 +$5.29 (+33.87%)

NYSE · 30 Oct 2026 20:00 UTC

Previous Close

$20.01

Day Range

$20.79$21.22

Year Range

$13.35$21.22

Market Cap

66.81B

AVG Volume

3.01M

Trailing/Forward PE

27.16/0.2

PEG ratio

3.39

Dividend Yield

3.04%

Next Earnings Date

2027-01-28

Primary Exchange

New York Stock Exchange

Revenue (JPY) · A

TAK Revenue (JPY) by year
Period	Revenue (JPY)
2025	4.55T
2024	4.58T
2023	4.26T
2022	4.03T
2021	3.57T
2020	3.2T
2019	3.29T
2018	2.1T
2017	1.77T
2016	1.73T

Net Income (JPY) · A

TAK Net Income (JPY) by year
Period	Net Income (JPY)
2025	193.19B
2024	107.88B
2023	144.07B
2022	317.02B
2021	230.06B
2020	376B
2019	2.69B
2018	109.13B
2017	186.89B
2016	114.94B

Operating Income (JPY) · A

TAK Operating Income (JPY) by year
Period	Operating Income (JPY)
2025	495.17B
2024	342.62B
2023	214.07B
2022	490.5B
2021	460.84B
2020	509.27B
2019	41.69B
2018	204.97B
2017	241.79B
2016	155.87B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (JPY) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 28 Jan 2027.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Takeda Pharmaceutical Company Limited

Earnings: TAK

Video analysis: TAK

News: TAK

Similar companies